STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZVSA
  4. [8-K] ZyVersa Therapeutics, Inc. Reports Material Event

[8-K] ZyVersa Therapeutics, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ZVSA logo
ZyVersa Therapeutics Inc

NASDAQ:ZVSA

ZVSA Rankings

#11282 Ranked by Market Cap
N/A Ranked by Dividends

ZVSA Latest News

Jul 8, 2025
ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds
Jul 8, 2025
ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis
Jun 26, 2025
ZyVersa Therapeutics Announces First Clinical Site Activation, Initiating Patient Recruitment for Cholesterol Efflux Mediator™ VAR 200’s Phase 2a Clinical Trial in Patients with Diabetic Kidney Disease (DKD)
Jun 25, 2025
ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership with Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol Efflux Mediator™ VAR 200
May 20, 2025
ZyVersa Therapeutics Highlights Published Study Reinforcing That Microglia-driven Inflammation Is Pivotal in Development of Parkinson’s and Alzheimer’s Diseases

ZVSA Latest SEC Filings

Jul 16, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity
Jul 15, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity
Jul 15, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity
Jul 15, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity
Jul 15, 2025
[Form 4] ZyVersa Therapeutics, Inc. Insider Trading Activity

ZVSA Stock Data

3.78M
4.87M
0.25%
3.23%
1.77%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOMERVILLE